Some groups found that METTL1 is tumor-promoting in colon cancer, hepatocellular carcinoma, and head and neck squamous cell carcinoma [15–19]; additionally, opposite findings have also been reported [20, 21]. This evidence concerns the gene METTL1 and head and neck squamous cell carcinoma.